Literature DB >> 29705433

Outcomes of deviation from treatment guidelines in status epilepticus: A systematic review.

Preena Uppal1, Michael Cardamone2, John A Lawson2.   

Abstract

OBJECTIVE: Due to a gap between published clinical guidelines on status epilepticus SE and clinician management of SE, a systematic review was performed to investigate treatment adherence to SE guidelines and its impact on patient outcomes.
METHODS: Medline and Embase searches were conducted for studies appraising adherence to SE guidelines (from 1970 and 1st April 2018). The quality of eligible studies was assessed by QUADAS- 2 criteria. Comparison was made between patients where guidelines were followed and not followed. Various patient outcomes including intubation, ICU admission, morbidity and mortality were compared. A Forest plot was used to investigate the effect of adherence on outcome.
RESULTS: A total of 3424 titles and abstracts were screened from the initial search after removal of duplicates. A total of 441 full text articles were reviewed in detail, and 22 articles were included in this study. The proportion of deviations ranged from 10.7% to 66.1%. Four studies were descriptive. Eighteen studies looked at the adverse effects of non-adherence. Eight studies showed respiratory depression and intubation were associated with excessive benzodiazepine use. A subset analysis showed 5.79 times higher odds of respiratory depression and intubation], if excessive benzodiazepines were given. The next most common variations were delayed management and insufficient treatment. These variations from the guidelines were associated with prolonged seizures.
CONCLUSIONS: This review provides preliminary evidence that non-adherence to SE guidelines negatively impacts on patient outcomes. Appropriate and timely treatment is imperative for rapid seizure termination and improving outcomes.
Copyright © 2018 British Epilepsy Association. All rights reserved.

Entities:  

Keywords:  Guideline adherence; Guidelines; Management; Seizure; Status epilepticus

Mesh:

Year:  2018        PMID: 29705433     DOI: 10.1016/j.seizure.2018.04.005

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  6 in total

Review 1.  [Management of refractory and super-refractory status epilepticus].

Authors:  Frank Erbguth
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-28       Impact factor: 0.840

2.  Epidemiology, management and outcome of status epilepticus in adults: single-center Italian survey.

Authors:  Carlotta Mutti; Angelo Sansonetti; Giampiero Monti; Claudia Vener; Irene Florindo; Anna Elisabetta Vaudano; Irene Trippi; Giorgia Bernabè; Liborio Parrino; Lucia Zinno
Journal:  Neurol Sci       Date:  2021-09-06       Impact factor: 3.307

3.  Benzodiazepine administration patterns before escalation to second-line medications in pediatric refractory convulsive status epilepticus.

Authors:  Theodore Sheehan; Marta Amengual-Gual; Alejandra Vasquez; Nicholas S Abend; Anne Anderson; Brian Appavu; Ravindra Arya; Cristina Barcia Aguilar; J Nicholas Brenton; Jessica L Carpenter; Kevin E Chapman; Justice Clark; Raquel Farias-Moeller; William D Gaillard; Marina Gaínza-Lein; Tracy A Glauser; Joshua L Goldstein; Howard P Goodkin; Réjean M Guerriero; Linda Huh; Michele Jackson; Kush Kapur; Robert Kahoud; Yi-Chen Lai; Tiffani L McDonough; Mohamad A Mikati; Lindsey A Morgan; Edward J Novotny; Adam P Ostendorf; Eric T Payne; Katrina Peariso; Juan Piantino; Latania Reece; James J Riviello; Tristan T Sands; Kumar Sannagowdara; Renee Shellhaas; Garnett Smith; Robert C Tasker; Dmitry Tchapyjnikov; Alexis A Topjian; Mark S Wainwright; Angus Wilfong; Korwyn Williams; Bo Zhang; Tobias Loddenkemper
Journal:  Epilepsia       Date:  2021-08-21       Impact factor: 6.740

4.  Continuous EEG use and status epilepticus treatment in Australasia: a practice survey of Australian and New Zealand epileptologists.

Authors:  Joshua Laing; Nicholas Lawn; Piero Perucca; Patrick Kwan; Terence J O'Brien
Journal:  BMJ Neurol Open       Date:  2020-12-15

5.  Only a Fine Line Separates Genius, Insanity, and Anesthetic Medication for Coma Induction in Status Epilepticus.

Authors:  Jong Woo Lee
Journal:  Epilepsy Curr       Date:  2021-09-22       Impact factor: 7.500

6.  Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial.

Authors:  Abhishek G Sathe; Ellen Underwood; Lisa D Coles; Jordan J Elm; Robert Silbergleit; James M Chamberlain; Jaideep Kapur; Hannah R Cock; Nathan B Fountain; Shlomo Shinnar; Daniel H Lowenstein; Eric S Rosenthal; Robin A Conwit; Thomas P Bleck; James C Cloyd
Journal:  Epilepsia       Date:  2021-02-10       Impact factor: 5.864

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.